WEBINAR DETAILS
  • When
  • About
    Up to 80 percent of oncology trials miss accrual timelines due to eligibility compression and weak prescreen design. This session outlines how Gabrail Cancer Center converts clinical access and workflow discipline into predictable enrollment velocity.

    Who Should Attend
    • Biotech Clinical Operations Leaders
    • CRO Site Selection Teams
    • VP Clinical Development
    • Oncology Program Directors
    • Study Start-Up Executives
  • Agenda
    • Structural Causes of Oncology Accrual Failure: Enrollment breakdowns typically stem from design and workflow failures, not a lack of patients.
    • Community Oncology Advantage: Community access reduces academic bottlenecks and increases screening throughput.
    • Prescreen Infrastructure as a Leading KPI: Real-time identification predicts accrual durability before timelines slip.
    • Activation Velocity and Time-to-First-Screen: Early screening speed is a predictive signal of enrollment stability.
    • Sponsor Metrics That Predict Enrollment Stability: Screen-to-enroll ratios and cohort momentum reveal trial viability early.
    • Q & A – Polls – Handouts We will collect your input through live polls, answer executive questions, and provide a downloadable Accrual Readiness resource.
  • Duration
    1 hour
  • Price
    Free
  • Language
    English
  • OPEN TO
    Everyone
  • Dial-in Number
    Please register for this Webinar to view the dial-in info.
FEATURED PRESENTERS
HOSTED BY